Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 46

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2

Pegram, Laurel M., Liddle, Jennifer C., Xiao, Yao, Hoh, Maria, Rudolph, Johannes, Iverson, Dylan B., Vigers, Guy P., Smith, Darin, Zhang, Hailong, Wang, Weiru, Moffat, John G., Ahn, Natalie G. · 2019 · Proceedings of the National Academy of Sciences

Published version of a preprint

Abstract

Conformational selection by small molecules expands inhibitory possibilities for protein kinases. Nuclear magnetic resonance (NMR) measurements of the mitogen-activated protein (MAP) kinase ERK2 have shown that activation by dual phosphorylation induces global motions involving exchange between two states, L and R. We show that ERK inhibitors Vertex-11e and SCH772984 exploit the small energetic difference between L and R to shift the equilibrium in opposing directions. An X-ray structure of active 2P-ERK2 complexed with AMP-PNP reveals a shift in the Gly-rich loop along with domain closure to position the nucleotide in a more catalytically productive conformation relative to inactive 0P-ERK2:ATP. X-ray structures of 2P-ERK2 complexed with Vertex-11e or GDC-0994 recapitulate this closure, which is blocked in a complex with a SCH772984 analog. Thus, the L→R shift in 2P-ERK2 is associated with movements needed to form a competent active site. Solution measurements by hydrogen-exchange mass spectrometry (HX-MS) reveal distinct binding interactions for Vertex-11e, GDC-0994, and AMP-PNP with active vs. inactive ERK2, where the extent of HX protection correlates with R state formation. Furthermore, Vertex-11e and SCH772984 show opposite effects on HX near the activation loop. Consequently, these inhibitors differentially affect MAP kinase phosphatase activity toward 2P-ERK2. We conclude that global motions in ERK2 reflect conformational changes at the active site that promote productive nucleotide binding and couple with changes at the activation loop to allow control of dephosphorylation by conformationally selective inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1906824116

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 29

  1. K. Burkhard, S. Smith, R. Deshmukh, A. D. MacKerellJr, P. Shapiro, Development of extracellular signal-regulated kinase inhibitors. Curr. Top. Med. Chem. 9, 678–689 (2009). · DOI
  2. M. B. Ryan, C. J. Der, A. Wang-Gillam, A. D. Cox, Targeting RAS-mutant cancers: Is ERK the key? Trends Cancer 1, 183–198 (2015). · DOI
  3. M. Huse, J. Kuriyan, The conformational plasticity of protein kinases. Cell 109, 275–282 (2002). · DOI · Paper page
  4. A. N. Hoofnagle, K. A. Resing, E. J. Goldsmith, N. G. Ahn, Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange. Proc. Natl. Acad. Sci. U.S.A. 98, 956–961 (2001). · DOI
  5. Y. Xiao, J. C. Liddle, A. Pardi, N. G. Ahn, Dynamics of protein kinases: Insights from nuclear magnetic resonance. Acc. Chem. Res. 48, 1106–1114 (2015). · DOI
  6. Y. Xiao ., Phosphorylation releases constraints to domain motion in ERK2. Proc. Natl. Acad. Sci. U.S.A. 111, 2506–2511 (2014). · DOI · Paper page
  7. A. M. Aronov ., Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control. J. Med. Chem. 52, 6362–6368 (2009). · DOI
  8. J. Rudolph, Y. Xiao, A. Pardi, N. G. Ahn, Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors. Biochemistry 54, 22–31 (2015). · DOI
  9. T. Lee, A. N. Hoofnagle, K. A. Resing, N. G. Ahn, Hydrogen exchange solvent protection by an ATP analogue reveals conformational changes in ERK2 upon activation. J. Mol. Biol. 353, 600–612 (2005). · DOI
  10. K. M. Sours, Y. Xiao, N. G. Ahn, Extracellular-regulated kinase 2 is activated by the enhancement of hinge flexibility. J. Mol. Biol. 426, 1925–1935 (2014). · DOI · Paper page
  11. Z. Zhao ., Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery? ACS Chem. Biol. 9, 1230–1241 (2014). · DOI · Paper page
  12. J. F. Blake ., Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor in early clinical development. J. Med. Chem. 59, 5650–5660 (2016). · DOI
  13. M. J. Knape, F. W. Herberg, Metal coordination in kinases and pseudokinases. Biochem. Soc. Trans. 45, 653–663 (2017). · DOI
  14. J. Zhang, P. Shapiro, E. Pozharski, Structure of extracellular signal-regulated kinase 2 in complex with ATP and ADP. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 68, 1434–1439 (2012). · DOI
  15. B. C. Lechtenberg ., Structure-guided strategy for the development of potent bivalent ERK inhibitors. ACS Med. Chem. Lett. 8, 726–731 (2017). · DOI
  16. K. Smorodinsky-Atias ., Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation. Mol. Biol. Cell 27, 1026–1039 (2016). · DOI
  17. D. Barr ., Importance of domain closure for the autoactivation of ERK2. Biochemistry 50, 8038–8048 (2011). · DOI
  18. A. Chaikuad ., A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics. Nat. Chem. Biol. 10, 853–860 (2014). · DOI · Paper page
  19. H. Maity, W. K. Lim, J. N. Rumbley, S. W. Englander, Protein hydrogen exchange mechanism: Local fluctuations. Protein Sci. 12, 153–160 (2003). · DOI
  20. J. Basken ., Specificity of phosphorylation responses to mitogen activated protein (MAP) kinase pathway inhibitors in melanoma cells. Mol. Cell. Proteomics 17, 550–564 (2018). · DOI
  21. Y. Zhao, Z. Y. Zhang, The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinase phosphatase 3. J. Biol. Chem. 276, 32382–32391 (2001). · DOI · Paper page
  22. W. F. Waas, K. N. Dalby, Physiological concentrations of divalent magnesium ion activate the serine/threonine specific protein kinase ERK2. Biochemistry 42, 2960–2970 (2003). · DOI
  23. P. Strop, S. L. Mayo, Contribution of surface salt bridges to protein stability. Biochemistry 39, 1251–1255 (2000). · DOI · Paper page
  24. P. Roser, J. Weisner, J. R. Simard, D. Rauh, M. Drescher, Direct monitoring of the conformational equilibria of the activation loop in the mitogen-activated protein kinase p38α. Chem. Commun. (Camb.) 54, 12057–12060 (2018). · DOI
  25. J. A. H. Gilburt ., Dynamic equilibrium of the Aurora A kinase activation loop revealed by single-molecule spectroscopy. Angew. Chem. Int. Ed. Engl. 56, 11409–11414 (2017). · DOI
  26. E. F. Ruff ., A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation. eLife 7, e32766 (2018). · DOI
  27. J. A. H. Gilburt, P. Girvan, J. Blagg, L. Ying, C. A. Dodson, Ligand discrimination between active and inactive activation loop conformations of Aurora-A kinase is unmodified by phosphorylation. Chem. Sci. (Camb.) 10, 4069–4076 (2019). · doi:10.1039/c8sc03669a
  28. E. W. Lake ., Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states. Proc. Natl. Acad. Sci. U.S.A. 115, E11894–E11903 (2018).
  29. S. B. Hari, E. A. Merritt, D. J. Maly, Conformation-selective ATP-competitive inhibitors control regulatory interactions and noncatalytic functions of mitogen-activated protein kinases. Chem. Biol. 21, 628–635 (2014). · DOI

Cited by

See all 46

Metadata

Authors
Pegram, L. M., Liddle, J. C., Xiao, Y., Hoh, M., Rudolph, J., Iverson, D. B., Vigers, G. P., Smith, D., Zhang, H., Wang, W., Moffat, J. G., & Ahn, N. G.
Affiliations
  • Department of Biochemistry, University of Colorado, Boulder, CO 80305;
  • Structural Biology Group, Array BioPharma Inc., Boulder, CO 80301;
  • Structural Biology and Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA 94080
Venue
Proceedings of the National Academy of Sciences
Published
2019-07-16
Volume
116
Issue
31
Pages
15463-15468
ISSN
  • 0027-8424
  • 1091-6490
Cited by
46
References
7
Language
en
Funders
  • HHS | NIH | National Institute of General Medical Sciences (R01GM114594, T32GM08759)
  • HHS | National Institutes of Health (S10RR026641)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. https://app.cochat.ai/papers/10.1073/pnas.1906824116
The paper
Pegram, L. M., Liddle, J. C., Xiao, Y., Hoh, M., Rudolph, J., Iverson, D. B., Vigers, G. P., Smith, D., Zhang, H., Wang, W., Moffat, J. G., & Ahn, N. G. (2019). Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1906824116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.